Key Points
- Director Lawrence Erik Kurzius purchased 2,000 shares of Cooper Companies at an average price of $82.50 (total $165,000) on Dec. 17, bringing his ownership to 7,777 shares — a 34.62% increase.
- Cooper Companies reported quarterly EPS of $1.15 vs. $1.11 expected and revenue of $1.07 billion, set FY2026 guidance of 4.450–4.600 EPS, and its board authorized a $2.0 billion stock buyback (up to ~15.4% of shares).
- The stock traded at $82.99 (up 0.6%), has a market cap of $16.26 billion and a consensus analyst rating of "Moderate Buy" with an average price target of $90.15.
The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) Director Lawrence Erik Kurzius purchased 2,000 shares of the stock in a transaction that occurred on Wednesday, December 17th. The shares were acquired at an average cost of $82.50 per share, with a total value of $165,000.00. Following the completion of the transaction, the director owned 7,777 shares in the company, valued at $641,602.50. This trade represents a 34.62% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
Lawrence Erik Kurzius also recently made the following trade(s):
- On Monday, September 29th, Lawrence Erik Kurzius acquired 2,000 shares of Cooper Companies stock. The stock was acquired at an average price of $68.39 per share, for a total transaction of $136,780.00.
Cooper Companies Stock Up 0.6%
Shares of COO stock traded up $0.51 during trading hours on Thursday, hitting $82.99. 253,969 shares of the company's stock traded hands, compared to its average volume of 2,460,825. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30. The stock's fifty day simple moving average is $74.16 and its two-hundred day simple moving average is $71.81. The Cooper Companies, Inc. has a 12-month low of $61.78 and a 12-month high of $100.24. The stock has a market cap of $16.26 billion, a price-to-earnings ratio of 44.00, a PEG ratio of 2.31 and a beta of 1.05.
Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. The company had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The firm's quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.04 EPS. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. On average, analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.
Cooper Companies declared that its Board of Directors has authorized a stock repurchase plan on Wednesday, September 17th that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the medical device company to repurchase up to 15.4% of its stock through open market purchases. Stock buyback plans are typically a sign that the company's board of directors believes its shares are undervalued.
Analyst Ratings Changes
A number of brokerages recently issued reports on COO. Mizuho set a $100.00 price target on shares of Cooper Companies and gave the stock an "outperform" rating in a research note on Friday, December 5th. Needham & Company LLC reaffirmed a "buy" rating and issued a $100.00 target price (up from $94.00) on shares of Cooper Companies in a report on Friday, December 5th. JPMorgan Chase & Co. upped their target price on shares of Cooper Companies from $66.00 to $78.00 and gave the stock a "neutral" rating in a research note on Friday, December 5th. Weiss Ratings reissued a "sell (d+)" rating on shares of Cooper Companies in a research report on Monday. Finally, Robert W. Baird boosted their price objective on shares of Cooper Companies from $85.00 to $98.00 and gave the stock an "outperform" rating in a report on Friday, December 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, Cooper Companies has a consensus rating of "Moderate Buy" and an average price target of $90.15.
Read Our Latest Stock Report on COO
Institutional Trading of Cooper Companies
Institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its holdings in shares of Cooper Companies by 1.8% during the second quarter. Vanguard Group Inc. now owns 24,254,677 shares of the medical device company's stock valued at $1,725,963,000 after purchasing an additional 421,423 shares during the last quarter. Capital World Investors boosted its holdings in Cooper Companies by 25.7% in the third quarter. Capital World Investors now owns 10,551,592 shares of the medical device company's stock worth $723,417,000 after purchasing an additional 2,159,233 shares during the last quarter. State Street Corp grew its position in Cooper Companies by 1.2% in the 2nd quarter. State Street Corp now owns 8,659,741 shares of the medical device company's stock worth $616,227,000 after purchasing an additional 104,910 shares during the period. Wellington Management Group LLP raised its stake in Cooper Companies by 332.9% during the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company's stock valued at $424,043,000 after buying an additional 4,756,178 shares during the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of Cooper Companies by 2.5% during the 2nd quarter. Geode Capital Management LLC now owns 5,205,615 shares of the medical device company's stock valued at $368,893,000 after buying an additional 127,907 shares during the period. Hedge funds and other institutional investors own 24.39% of the company's stock.
About Cooper Companies
(
Get Free Report)
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
